SANUWAVE Health, Inc. (SNWV) is a Healthcare stock trading at $9.18 (as of 2026-06-18), with a market capitalization of $141.63M and a trailing P/E of 16.3. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.
SANUWAVE Health, Inc. researches, develops, and commercializes noninvasive, high-energy acoustic shock-wave therapies and ultrasound-based treatments. Its products include dermaPACE for diabetic foot ulcers, UltraMIST for ulcer and wound conditions, and orthoPACE for tendinopathies, serving healthcare applications in wound healing and related musculoskeletal and vascular care.